JP Morgan Chase’s Axalta AXTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,700
Closed -$3.08M 6909
2023
Q1
$3.08M Buy
+101,700
New +$2.92M ﹤0.01% 3198
2021
Q4
Sell
-54,400
Closed -$1.59M 6631
2021
Q3
$1.59M Buy
+54,400
New +$1.63M ﹤0.01% 3962
2020
Q4
Sell
-15,500
Closed -$342K 5624
2020
Q3
$342K Buy
+15,500
New +$359K ﹤0.01% 4145
2016
Q4
Sell
-1,659,121
Closed -$46.9M 4994
2016
Q3
$46.9M Hold
1,659,121
0.01% 869
2016
Q2
$44M Buy
+1,659,121
New +$47M 0.01% 894

Other funds holding AXTA

JP Morgan Chase's AXTA Position: Q1 2026 in Review

JP Morgan Chase reduced its Axalta (AXTA) stake by 68% in Q1 2026, selling an estimated $67M and leaving 978,979 shares worth $26.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1860.

JP Morgan Chase first reported a position in AXTA in Q3 2015 and has held it in 43 quarters since. The position peaked at $463M in Q4 2023. 381 funds tracked by Wall St. Rank hold AXTA as of Q1 2026.

  • JP Morgan Chase held 978,979 shares of Axalta worth $26.1M as of Q1 2026.
  • JP Morgan Chase sold 2,111,663 Axalta shares in Q1 2026, an estimated $67M.
  • Axalta made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1860 holding.
  • JP Morgan Chase first reported a position in Axalta in Q3 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Axalta position peaked at $463M in Q4 2023.
  • 381 funds tracked by Wall St. Rank held Axalta as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.